This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
NECTAR – Genetic Screening Component of AMBRoSIA (Biomarkers Study) Investments > €500k United Kingdom Motor neurone diseases 2016
A Multicentre Biomarker Resource Strategy in ALS: AMBRoSIA Investments > €500k United Kingdom Motor neurone diseases 2016
Optimising quality of living throughout the course of Motor Neurone Disease (Opt-Life) Investments > €500k United Kingdom Motor neurone diseases 2016
The role of low complexity domain mutations in RNA-binding proteins associated with Motor Neuron Disease pathogenesis Investments > €500k United Kingdom Motor neurone diseases 2016
Generation and characterisation of induced pluripotent stem cells from ALS lymphoblasts to model disease pathogenesis and advanced drug discovery Investments > €500k United Kingdom Motor neurone diseases 2016
The UK National Motor Neurone Disease Registry Investments > €500k United Kingdom Motor neurone diseases 2016
Extraction and modelling of Alzheimer’s disease data for patient stratification: integrative, multiplex network approach Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016
CloudUPDRS: Big Data Analytics for Parkinson’s Disease patient stratification Investments > €500k United Kingdom Parkinson’s disease & PD-related disorders 2016
A Digital Brain Health Platform for improving dementia outcomes Investments > €500k United Kingdom Neurodegenerative disease in general 2016
mTOR signalling pathway in the risk stratification for future cognitive decline in Mild Cognitive Impairment (MCI). Investments > €500k United Kingdom Neurodegenerative disease in general 2016
